Cargando…
Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
Gene mutations are involved in the development of malignant mesothelioma. Important mutations have been identified in the genes for cyclin-dependent kinase inhibitor 2A (p16) alternative reading frame, breast cancer-associated protein 1 (BAP1) and neurofibromatosis type 2 (NF2). Previously, the util...
Autores principales: | Takehara, Yusuke, Yamochi, Toshiko, Nagumo, Tasuku, Cho, Tomonari, Urushibara, Fumihiko, Ono, Kohei, Fujii, Tomonori, Okamoto, Naoko, Sasaki, Yosuke, Tazawa, Sakiko, Honma, Mayumi, Norose, Tomoko, Shiozawa, Eisuke, Tate, Genshu, Takimoto, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920880/ https://www.ncbi.nlm.nih.gov/pubmed/29731861 http://dx.doi.org/10.3892/ol.2018.8225 |
Ejemplares similares
-
Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018) -
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma
por: Urushibara, Fumihiko, et al.
Publicado: (2018) -
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019) -
Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review
por: Nakayama, Akihiro, et al.
Publicado: (2021) -
YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
por: Cunningham, Richard, et al.
Publicado: (2023)